Cisplatin Accord 1 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cisplatin accord 1 mg/ml koncentrat za raztopino za infundiranje

accord healthcare - cisplatin - koncentrat za raztopino za infundiranje - cisplatin 1 mg / 1 ml - cisplatin

Cisplatin Accord 1 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cisplatin accord 1 mg/ml koncentrat za raztopino za infundiranje

accord healthcare - cisplatin - koncentrat za raztopino za infundiranje - cisplatin 1 mg / 1 ml - cisplatin

Cisplatin Accord 1 mg/ml koncentrat za raztopino za infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cisplatin accord 1 mg/ml koncentrat za raztopino za infundiranje

accord healthcare - cisplatin - koncentrat za raztopino za infundiranje - cisplatin 1 mg / 1 ml - cisplatin

Lunsumio Evropska unija - slovenščina - EMA (European Medicines Agency)

lunsumio

roche registration gmbh - mosunetuzumab - limfom, folikularni - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Tecvayli Evropska unija - slovenščina - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.